Parietal GABA in individuals with amyotrophic lateral sclerosis and asymptomatic C9orf72 repeat expansion carriers assessed with MR spectroscopy at 7 T

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Multiple pathways are involved in its pathophysiology, but the exact mechanisms are still unknown. In this study, we investigate the role of gamma-aminobutyric acid (GABA) in ALS and the related C9orf72 repeat expansion (C9). As the primary inhibitory neurotransmitter, GABA may affect hyperexcitability in ALS. Decreased GABA levels have been reported in the motor cortex in ALS, but neither regions outside the motor area nor carriers of ALS-related pathogenic genetic variants were investigated. We used GABA-edited magnetic resonance spectroscopy (MEGA-sLASER) at 7 T to examine ratios of GABA to creatine. We compared individuals with ALS (n = 17) to controls (n = 13) and separately compare asymptomatic C9orf72 repeat expansion carriers (n = 5) to non-carriers (n = 7) from a single family. We placed the voxel of interest in the parietal lobe as it is specifically at risk in C9 carriers. We found no statistically significant differences in mean GABA ratios in either comparison, but individuals with ALS showed a higher variance than controls (p = 0.026). We conclude that parietal GABA is not involved in ALS pathology in all individuals with ALS, but increased variance indicates heterogeneity and may reflect subgroups with GABAergic dysfunction.

Authors

Institutions

Publication Details

Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Published
2026-11-18
DOI
https://doi.org/10.1080/21678421.2026.2762726
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Parietal GABA in individuals with amyotrophic lateral sclerosis and asymptomatic C9orf72 repeat expansion carriers assessed with MR spectroscopy at 7 T

Dennis W. J. Klomp, Jannie P. Wijnen, Henk‐Jan Westeneng, Wytse van Hoek et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Amyotrophic Lateral Sclerosis Research
article

Parietal GABA in individuals with amyotrophic lateral sclerosis and asymptomatic C9orf72 repeat expansion carriers assessed with MR spectroscopy at 7 T

Dennis W. J. Klomp, Jannie P. Wijnen, Henk‐Jan Westeneng, Wytse van Hoek, Carrie Wismans, Abram D. Nitert, Leonard H. van den Berg, Kevin van Veenhuijzen, Harold H. G. Tan
article en

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Multiple pathways are involved in its pathophysiology, but the exact mechanisms are still unknown. In this study, we investigate the role of gamma-aminobutyric acid (GABA) in ALS and the related C9orf72 repeat expansion (C9). As the primary inhibitory neurotransmitter, GABA may affect hyperexcitability in ALS. Decreased GABA levels have been reported in the motor cortex in ALS, but neither regions outside the motor area nor carriers of ALS-related pathogenic genetic variants were investigated. We used GABA-edited magnetic resonance spectroscopy (MEGA-sLASER) at 7 T to examine ratios of GABA to creatine. We compared individuals with ALS (n = 17) to controls (n = 13) and separately compare asymptomatic C9orf72 repeat expansion carriers (n = 5) to non-carriers (n = 7) from a single family. We placed the voxel of interest in the parietal lobe as it is specifically at risk in C9 carriers. We found no statistically significant differences in mean GABA ratios in either comparison, but individuals with ALS showed a higher variance than controls (p = 0.026). We conclude that parietal GABA is not involved in ALS pathology in all individuals with ALS, but increased variance indicates heterogeneity and may reflect subgroups with GABAergic dysfunction.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Utrecht University (NL), University Medical Center Utrecht (NL)
Stichting ALS Nederland
Good health and well-being
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon